Product Name: CEP-18770
Synonyms: CEP-18770;[(1R)-1-[[(2S,3R)-3-Hydroxy-2-[[(6-phenylpyridin-2-yl)carbonyl]amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid;CIP 18770;CT 47098;Delanzomib;NPH 007098;DelanzoMib
(CEP-18770);Boronic acid, B-[(1R)-1-[[(2S,3R)-3-hydroxy-1-oxo-2-[[(6-phenyl-2-pyridinyl)carbonyl]aMino]butyl]aMino]-3-Methylbutyl]-
CAS: 847499-27-8
MF: C21H28BN3O5
MW: 413.27512
Product Categories: Inhibitor
density 1.207
Purity : 99%
Appearance : White powders
Package : 1kg/foil bag
Usage : CEP-18770 (Delanzomib) is an orally active inhibitor of the chymotrypsin-like activity of proteasome with IC50 of 3.8 nM, with only marginal inhibition of the tryptic and peptidylglutamyl
activities of the proteosome.